C0533187||apigenin trimethyl ether
C0034721||rat
C0032105||plasma
C4049918||liquid chromatography-tandem mass spectrometry
C0201734||pharmacokinetic study
C0533187||Apigenin trimethyl ether
C0533187||5,7,4'-trimethoxyflavone
C0533187||ATE
C0016219||polymethoxyflavone
C0517496||health-promoting activities
C2603343||study
C4049918||liquid chromatography-tandem mass spectrometry
C4049918||LC-MS/MS
C0025663||method
C1519941||validated
C0533187||ATE
C0034721||rat
C0032105||plasma
C3815102||Protein precipitation
C0032105||plasma
C1516801||electrospray ionization
C0533187||ATE
C0060656||formononetin
C0025663||multiple reactions monitoring
C0533187||ATE
C0060656||formononetin
C4049918||LC-MS/MS method
C0533187||ATE
C0332128||examined
C0034715||Sprague-Dawley rats
C0001563||oral administration
C0038960||aqueous suspension
C0533187||ATE
C0032105||plasma
C0442027||oral
C0524527||formulated
C0046237||2-hydroxypropyl-Î²-cyclodextrin
C0442027||oral
C0533187||ATE
C0184511||substantially improved
C0442027||oral
C0533187||ATE
C2603343||study
C0013227||medicinal
C3494260||exploration
C0533187||ATE